OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
408259

Daiichi Kigenso Kagaku Kogyo Co Ltd

Commodity ChemicalsVerified

Daiichi Kigenso Kagaku Kogyo Co Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.56, below the industry median of 0.85, and a current ratio of 3.67, indicating strong short-term liquidity. The company holds 8.92 billion JPY in cash and equivalents, but its long-term debt of 21.35 billion JPY results in a net cash position of -12.43 billion JPY, raising liquidity concerns. Free cash flow of 2.13 billion JPY in the latest period supports operational flexibility, though capital expenditures of -1.63 billion JPY suggest ongoing investment in production capacity. Profitability metrics show a return on equity of 2.09% and return on assets of 1.22%, both below the industry median of 3.5% and 2.1%, respectively. Gross profit of 8.35 billion JPY on 33.64 billion JPY in revenue yields a 24.8% margin, which is in line with the industry median of 25.3%. However, operating income of 3.30 billion JPY (9.8% margin) and net income of 793 million JPY (2.4% margin) indicate pressure from operating and non-operating expenses. The company operates as a single business segment, with no disclosed geographic revenue breakdown. Given its focus on zirconium compounds, it is likely concentrated in domestic Japanese markets, though this is not explicitly stated in the input data. No material revenue concentration risks are identified in the input data. Outlook for the current fiscal year shows revenue growth of 4.9% to 35.3 billion JPY, with net income expected to increase by 117% to 70.3 JPY per share. This outperforms the industry median revenue growth of 2.1% and EPS growth of 8.4%, suggesting strong demand for zirconium-based products. The company’s capital expenditures and free cash flow suggest a balance between growth and financial discipline. Risk assessment highlights medium liquidity risk due to the net cash deficit and low dilution risk, with no material dilution sources identified in the input data. No recent filings or transcripts are provided to assess near-term operational or strategic risks. Recent analyst estimates indicate strong performance relative to expectations, with actual revenue and EPS falling below the mean estimates but showing significant upside potential in the next reporting period.

30-day price · 4082(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyDaiichi Kigenso Kagaku Kogyo Co Ltd
Ticker4082.T
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Daiichi Kigenso Kagaku Kogyo Co Ltd produces and sells zirconium oxide and other zirconium compounds, primarily used in catalysts, electronic materials, and industrial applications.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with 92% confidence.

Daiichi Kigenso Kagaku Kogyo Co Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.56, below the industry median of 0.85, and a current ratio of 3.67, indicating strong short-term liquidity. The company holds 8.92 billion JPY in cash and equivalents, but its long-term debt of 21.35 billion JPY results in a net cash position of -12.43 billion JPY, raising liquidity concerns. Free cash flow of 2.13 billion JPY in the latest period supports operational flexibility, though capital expenditures of -1.63 billion JPY suggest ongoing investment in production capacity. Profitability metrics show a return on equity of 2.09% and return on assets of 1.22%, both below the industry median of 3.5% and 2.1%, respectively. Gross profit of 8.35 billion JPY on 33.64 billion JPY in revenue yields a 24.8% margin, which is in line with the industry median of 25.3%. However, operating income of 3.30 billion JPY (9.8% margin) and net income of 793 million JPY (2.4% margin) indicate pressure from operating and non-operating expenses. The company operates as a single business segment, with no disclosed geographic revenue breakdown. Given its focus on zirconium compounds, it is likely concentrated in domestic Japanese markets, though this is not explicitly stated in the input data. No material revenue concentration risks are identified in the input data. Outlook for the current fiscal year shows revenue growth of 4.9% to 35.3 billion JPY, with net income expected to increase by 117% to 70.3 JPY per share. This outperforms the industry median revenue growth of 2.1% and EPS growth of 8.4%, suggesting strong demand for zirconium-based products. The company’s capital expenditures and free cash flow suggest a balance between growth and financial discipline. Risk assessment highlights medium liquidity risk due to the net cash deficit and low dilution risk, with no material dilution sources identified in the input data. No recent filings or transcripts are provided to assess near-term operational or strategic risks. Recent analyst estimates indicate strong performance relative to expectations, with actual revenue and EPS falling below the mean estimates but showing significant upside potential in the next reporting period.
Key takeaways
  • Conservative capital structure with a debt-to-equity ratio of 0.56 and strong current ratio of 3.67.
  • Profitability metrics (ROE, ROA) lag behind industry medians, but gross margin is in line with peers.
  • Revenue and EPS growth outlook outperforms industry averages, suggesting strong demand for zirconium compounds.
  • Liquidity risk is elevated due to a net cash deficit, but free cash flow and low dilution risk support operational stability.
  • --
  • ## RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$33.64B
Gross profit$8.35B
Operating income$3.30B
Net income$793.0M
R&D
SG&A
D&A
SBC
Operating cash flow$3.50B
CapEx-$1.62B
Free cash flow$2.12B
Total assets$64.75B
Total liabilities$26.84B
Total equity$37.92B
Cash & equivalents$8.92B
Long-term debt$21.35B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$37.92B
Net cash-$12.43B
Current ratio3.7
Debt/Equity0.6
ROA1.2%
ROE2.1%
Cash conversion4.4%
CapEx/Revenue-4.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric4082Activity
Op margin9.8%0.4% medp25 -8.0% · p75 16.0%above median
Net margin2.4%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin24.8%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-4.8%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity56.0%59.0% medp25 54.9% · p75 72.9%below median
Observations
IR observations
Mean EPS estimate70.30 JPY
Last actual EPS32.64 JPY
Mean revenue estimate35,300,000,000 JPY
Last actual revenue33,641,000,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-07 07:14 UTC#e3a2c06f
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 12:09 UTCJob: ea5181d9